R. D. L. Barrera

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

Alison E Kosel, K. Meyer, M. Robb, 2017, The Lancet.

Fetal Neuropathology in Zika Virus-Infected Pregnant Female Rhesus Monkeys

S. Warfield, Mark G. Lewis, O. Afacan, 2018, Cell.

Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate given via standard versus accelerated vaccination schedules: a phase 1, single-center, double-blind, sequential-group, randomized, placebo-controlled clinical trial

Joseph, N. Michael, D. Barouch, 2020 .

Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys

A. Perelson, K. Best, D. Barouch, 2017, Cell.

Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants.

A. Nisalak, D. Vaughn, Stephen J. Thomas, 2008, The American journal of tropical medicine and hygiene.

Vaccine Protection Against Zika Virus from Brazil

Richard G. Jarman, Zhenfeng Li, Nelson L. Michael, 2016, Nature.

Vaccine Protection Against Zika Virus from Brazil

Stephen J. Thomas, N. Michael, R. Jarman, 2016, Nature.

Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1

A. Rothman, Stephen J. Thomas, R. Jarman, 2020, mSphere.